slider

Schedule an Appointment

Cancer Questions

Circle of Hope Blog

pharmacy banner

Residency

Hematology/Oncology Pharmacy Specialty Residency Program (PGY2)

American Society of Health-System Pharmacists (ASHP) Accredited

Huntsman Cancer Institute (HCI) is a state-of-the-art cancer research and treatment facility located in Salt Lake City, Utah. HCI is a National Cancer Institute (NCI)-Designated Cancer Center. The cancer hospital is part of the University of Utah Health system, which is a 660-bed tertiary academic medical center. The hospital at HCI opened in July 2004 with a major expansion completed in 2011. The cancer hospital includes the following:

  • 100 inpatient beds
  • 102 examination/procedure rooms
  • 84 treatment rooms
  • 68 infusion stations
  • 5 Linear accelerators
  • 2 digital mammography machines
  • 1 Intraoperative MRI
  • 1 daVinci Surgical Robot

HCI offers a directed 12-month postgraduate training program in oncology pharmacy practice. The program helps residents develop knowledge and skills to achieve competency in an oncology environment. Residents are involved in maintaining and improving oncology practice by providing pharmacy support in various service areas.

Upon completion of the residency, the pharmacist will be well prepared to practice in a variety of oncology settings. The program is accredited by the American Society of Health-System Pharmacists using the Standard for Residencies in Pharmacy Practice.

Please see the Pharmacy Residency website.

For more information contact:

Stephanie A. Sanders, BS, PharmD, BCOP
Residency Program Director, PGY2 Oncology
Clinical Pharmacist, Oncology Intensive Care
Adjunct Instructor, College of Pharmacy
Stephanie.Sanders@hci.utah.edu
801-213-4293

Sara Hiller deHoll, PharmD, BCOP
Residency Coordinator, PGY2 Oncology
Clinical Pharmacist, Oncology Intensive Care & Inpatient Hematology
Adjunct Instructor, College of Pharmacy
Sara.Hiller@hci.utah.edu
801-213-4293